Freda S Nunn
Examiner (ID: 8801, Phone: (571)272-2607 , Office: P/2916 )
Most Active Art Unit | 2911 |
Art Unit(s) | 2901, 2911, 2916, 2899 |
Total Applications | 8991 |
Issued Applications | 8887 |
Pending Applications | 0 |
Abandoned Applications | 103 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13590893
[patent_doc_number] => 20180346995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Process for Exploiting Synthetic Lethality Based on OverExpression of MYC Oncogene
[patent_app_type] => utility
[patent_app_number] => 15/996697
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996697
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996697 | Process for Exploiting Synthetic Lethality Based on OverExpression of MYC Oncogene | Jun 3, 2018 | Abandoned |
Array
(
[id] => 15797109
[patent_doc_number] => 20200121697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHODS FOR DIAGNOSING AND TREATING CACHEXIA
[patent_app_type] => utility
[patent_app_number] => 16/605785
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605785 | METHODS FOR DIAGNOSING AND TREATING CACHEXIA | May 29, 2018 | Abandoned |
Array
(
[id] => 13774509
[patent_doc_number] => 20190000793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS OF INDUCING ANESTHESIA
[patent_app_type] => utility
[patent_app_number] => 15/986656
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986656 | METHODS OF INDUCING ANESTHESIA | May 21, 2018 | Abandoned |
Array
(
[id] => 14273505
[patent_doc_number] => 20190134037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 15/966274
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15966274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/966274 | INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN | Apr 29, 2018 | Abandoned |
Array
(
[id] => 13397417
[patent_doc_number] => 20180250251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => Treatment of Patients with Familial Hypercholesterolemia on Lipid-Lowering Therapy
[patent_app_type] => utility
[patent_app_number] => 15/956232
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956232 | Treatment of Patients with Familial Hypercholesterolemia on Lipid-Lowering Therapy | Apr 17, 2018 | Abandoned |
Array
(
[id] => 16086679
[patent_doc_number] => 20200197326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
[patent_app_type] => utility
[patent_app_number] => 16/608783
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608783
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608783 | TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN | Apr 17, 2018 | Pending |
Array
(
[id] => 18027697
[patent_doc_number] => 11510856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Pramoxine compositions
[patent_app_type] => utility
[patent_app_number] => 15/916360
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21827
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/916360 | Pramoxine compositions | Mar 8, 2018 | Issued |
Array
(
[id] => 12904378
[patent_doc_number] => 20180193301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals
[patent_app_type] => utility
[patent_app_number] => 15/913646
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913646 | Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals | Mar 5, 2018 | Issued |
Array
(
[id] => 15493285
[patent_doc_number] => 20200046831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => NANOEMULSION COMPRISING IMIDAZOQUINOLINE-BASED MATERIAL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/485544
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485544 | NANOEMULSION COMPRISING IMIDAZOQUINOLINE-BASED MATERIAL AND USE THEREOF | Feb 12, 2018 | Abandoned |
Array
(
[id] => 12862024
[patent_doc_number] => 20180179182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => METHODS OF TREATMENT USING PYRROLIDINYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/851418
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851418 | Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds | Dec 20, 2017 | Issued |
Array
(
[id] => 15765545
[patent_doc_number] => 20200113790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => METHOD FOR IMPROVING THE SENSORIAL PROPERTIES OF OIL-IN-WATER EMULSIONS, TO REDUCE THE ADHESIVE EFFECT OF SUCH GLYCERIN-BASED OIL-IN-WATER EMULSIONS
[patent_app_type] => utility
[patent_app_number] => 16/470350
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470350 | METHOD FOR IMPROVING THE SENSORIAL PROPERTIES OF OIL-IN-WATER EMULSIONS, TO REDUCE THE ADHESIVE EFFECT OF SUCH GLYCERIN-BASED OIL-IN-WATER EMULSIONS | Dec 11, 2017 | Pending |
Array
(
[id] => 12621510
[patent_doc_number] => 20180099000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis
[patent_app_type] => utility
[patent_app_number] => 15/838595
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15838595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/838595 | Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis | Dec 11, 2017 | Abandoned |
Array
(
[id] => 14864641
[patent_doc_number] => 20190282562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => MEDICAL SKIN EXTERNAL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/465559
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465559 | Medical skin external preparation | Nov 29, 2017 | Issued |
Array
(
[id] => 12259447
[patent_doc_number] => 20180078644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'COMBINATION OF CAROTENOIDS AND EPI-LUTEIN'
[patent_app_type] => utility
[patent_app_number] => 15/823195
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8782
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15823195
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/823195 | COMBINATION OF CAROTENOIDS AND EPI-LUTEIN | Nov 26, 2017 | Abandoned |
Array
(
[id] => 12239842
[patent_doc_number] => 20180072705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/813741
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60777
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/813741 | Diaminopyrimidine derivatives and processes for the preparation thereof | Nov 14, 2017 | Issued |
Array
(
[id] => 17904260
[patent_doc_number] => 11458091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Compositions and methods for the treatment of opioid overdose
[patent_app_type] => utility
[patent_app_number] => 16/461354
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 35108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461354 | Compositions and methods for the treatment of opioid overdose | Nov 8, 2017 | Issued |
Array
(
[id] => 14743681
[patent_doc_number] => 20190255014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Therapeutic Cannabinoid Formulations and Methods for Their Use
[patent_app_type] => utility
[patent_app_number] => 16/347587
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347587 | Therapeutic Cannabinoid Formulations and Methods for Their Use | Nov 5, 2017 | Pending |
Array
(
[id] => 18825461
[patent_doc_number] => 11840732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Diagnostic methods
[patent_app_type] => utility
[patent_app_number] => 16/347763
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23954
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347763 | Diagnostic methods | Nov 2, 2017 | Issued |
Array
(
[id] => 12217415
[patent_doc_number] => 20180055774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/801409
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14626
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801409 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | Nov 1, 2017 | Abandoned |
Array
(
[id] => 12724168
[patent_doc_number] => 20180133223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => COMBINATION THERAPY WITH A PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY
[patent_app_type] => utility
[patent_app_number] => 15/800386
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15800386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/800386 | COMBINATION THERAPY WITH A PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY | Oct 31, 2017 | Abandoned |